International Journal of Medical Informatics
Volume 76 , Pages S447-S455 , December 2007

HIS modelling and simulation based cost–benefit analysis of a telemedical system for closed-loop diabetes therapy

  • Oliver J. Bott

      Affiliations

    • Institute for Medical Informatics, Technical University of Braunschweig, Muehlenpfordtstr. 23, D-38106 Braunschweig, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 531/391 9505; fax: +49 531/391 9502.
    web address
    • ,
  • Ina Hoffmann

      Affiliations

    • Institute for Medical Informatics, Technical University of Braunschweig, Muehlenpfordtstr. 23, D-38106 Braunschweig, Germany
    • ,
  • Joachim Bergmann

      Affiliations

    • Institute for Medical Informatics, Technical University of Braunschweig, Muehlenpfordtstr. 23, D-38106 Braunschweig, Germany
    • ,
  • Nathalie Gusew

      Affiliations

    • Institute for Medical Informatics, Technical University of Braunschweig, Muehlenpfordtstr. 23, D-38106 Braunschweig, Germany
    • ,
  • Oliver Schnell

      Affiliations

    • Diabetes Research Institute, Munich, Germany
    • ,
  • Enrique J. Gómez

      Affiliations

    • Bioengineering and Telemedicine Group, Universidad Politécnica de Madrid, Spain
    • ,
  • M. Elena Hernando

      Affiliations

    • Bioengineering and Telemedicine Group, Universidad Politécnica de Madrid, Spain
    • ,
  • Patrick Kosche

      Affiliations

    • Institute for Economic Sciences, Technical University of Braunschweig, Germany
    • ,
  • Christian von Ahn

      Affiliations

    • Institute for Economic Sciences, Technical University of Braunschweig, Germany
    • ,
  • Dirk C. Mattfeld

      Affiliations

    • Institute for Economic Sciences, Technical University of Braunschweig, Germany
    • ,
  • Dietrich P. Pretschner

      Affiliations

    • Institute for Medical Informatics, Technical University of Braunschweig, Muehlenpfordtstr. 23, D-38106 Braunschweig, Germany

Received 28 March 2007 ,Revised 15 May 2007 ,Accepted 5 June 2007.

References 

  1. Bashshur R, Shannon G, Sapci H. Telemedicine evaluation. Telemed. J. E. Health. 2005;11(3):296–316
  2. Reardon T. Research findings and strategies for assessing telemedicine costs. Telemed. J. E. Health. 2005;11(3):348–369
  3. Hjelmgren J, Berggren F, Andersson F. Health economic guidelines—similarities, differences and some implications. Value Health. 2001;4(3):225–250
  4. Klose T. A utility-theoretic model for QALYs and willingness to pay. Health Econ. 2003;12(1):17–31
  5. Gyrd-Hansen D. Willingness to pay for a QALY: theoretical and methodological issues. Pharmacoeconomics. 2005;23(5):423–432
  6. Hailey D. The need for cost-effectiveness studies in telemedicine. J. Telemed. Telecare. 2005;11(8):379–383
  7. Hebert MA, Korabek B, Scott RE. Moving research into practice: a decision framework for integrating home telehealth into chronic illness care. Int. J. Med. Inform. 2006;75(12):786–794
  8. Roine R, Ohinmaa A, Hailey D. Assessing telemedicine: a systematic review of the literature. CMAJ. 2001;165(6):765–771
  9. Whitten PS, Mair FS, Haycox A, May CR, Williams TL, Hellmich S. Systematic review of cost effectiveness studies of telemedicine interventions. BMJ. 2002;324(7351):1434–1437
  10. Hailey D, Roine R, Ohinmaa A. Systematic review of evidence for the benefits of telemedicine. J. Telemed. Telecare. 2002;8(Suppl. 1):1–30
  11. Aoki N, Dunn K, Johnson-Throop KA, Turley JP. Outcomes and methods in telemedicine evaluation. Telemed. J. E. Health. 2003;9(4):393–401
  12. Hailey D, Ohinmaa A, Roine R. Study quality and evidence of benefit in recent assessments of telemedicine. J. Telemed. Telecare. 2004;10(6):318–324
  13. Hailey D, Jennett P. The need for economic evaluation of telemedicine to evolve: the experience in Alberta, Canada. Telemed. J. E. Health. 2004;10(1):71–76
  14. Farmer A, Gibson OJ, Tarassenko L, Neil A. A systematic review of telemedicine interventions to support blood glucose self-monitoring in diabetes. Diabet. Med. 2005;22(October (10)):1372–1378
  15. Hernando ME, Gomez EJ, Gili A, Gomez M, Garcia G, del Pozo F. New trends in diabetes management: mobile telemedicine closed-loop system. Stud. Health Technol. Inform. 2004;105:70–79
  16. Larizza C, Bellazzi R, Stefanelli M, Ferrari P, De Cata P, Gazzaruso C, et al. The M2DM project—the experience of two Italian clinical sites with clinical evaluation of a multi-access service for the management of diabetes mellitus patients. Methods Inf. Med. 2006;45(1):79–84
  17. E.J. Gómez, M.E. Hernando, A. Garcia, F. del Pozo, R. Corcoy, E. Brugués, J. Cermeño, A. de Leiva, Telemedicine as a tool for intensive management of diabetes: the DIABTel experience, in: Comp. Meth. and Prog. in Biomedicine, vol. 69, Elsevier Science Ireland Ltd. (2002) 163–177.
  18. Hovorka R, Chassin LJ, Wilinska ME. Closing the loop: the Adicol experience. Diab. Technol. Ther. 2004;6(3):307–318
  19. American Association of Diabetes Educators . Intensive diabetes management: implications of the DCCT and UKPDS. Diab. Educ. 2002;28(September–October (5)):735–740
  20. T. Kaupper, H. Rauch, O. Bott, E. Hernando, I. Hoffmann, E. Standl, D. Pretschner, E. Gomez, O. Schnell, INCA: Mobil- und Internettechnologie zur Sensor-gestützten Insulinpumpentherapie—Ein neuer Weg zur Closed-Loop Applikation (INCA: mobile and internet technology for sensor based insulin therapy—a new way towards closed-loop application, in German), Diabetologie 1 (2006) S23–S172 (Georg Thieme Verlag, KG Stuttgart, New York, ISSN 1861-9002, p. 95).
  21. Bott OJ, Bergmann J, Hoffmann I, Vering T, Gomez EJ, Hernando ME, et al. The INCA-project: specifying a telemedical system for closed-loop therapy of diabetes using MOSAIK-M. Stud. Health Technol. Inform. 2005;116:503–508
  22. Wendt T, Häber A, Brigl B, Winter A. Modeling hospital information systems (part 2): using the 3LGM2 tool for modeling patient record management. Methods Inf. Med. 2004;43(3):256–267
  23. Girault C, Valk R. Petri Nets for System Engineering: A Guide to Modeling, Verification, and Applications. Berlin: Springer; 2003;
  24. J. Rumbaugh, I. Jacobson, G. Booch, The Unified Modeling Language Reference Manual, Addison-Wesley, 2004.
  25. EBM2000 Plus, 2000, http://www.ebm2000plus.de/ (in German, last accessed on February 14, 2007).
  26. Praxis-Leitlinien der Deutschen Diabetes-Gesellschaft (Practice Guidelines of the German Diabetes Association), Diabetes und Stoffwechsel, Suppl. 2, 2002.
  27. Davidson JA. Treatment of the patient with diabetes: importance of maintaining target HbA(1c) levels. Curr. Med. Res. Opin. 2004;20(December (12)):1919–1927
  28. Schlessinger L, Eddy DM. Archimedes: a new model for simulating health care systems—the mathematical formulation. J. Biomed. Inform. 2002;35:37–50
  29. Eddy DM, Schlessinger L. Validation of the Archimedes diabetes model. Diab. Care. 2003;26(11):3102–3110
  30. http://www.diabetes.org/diabetesphd/default.jsp (last accessed on January 3, 2006).
  31. L. von Ferber, Die direkten Kosten der Komplikationen bei diabetes mellitus (The direct costs of diabetes mellitus related complications), in: Presentation of the 39th Conference of the Deutsche Diabetes Gesellschaft, http://www.pmvforschungsgruppe.de/pdf/03_publikationen/ kodim_lvf_2004.pdf (in German, last accessed on January 3, 2006), 19–22 May 2004 in Hannover (Germany).
  32. Scheer A-W. ARIS-Business Process Modelling. second ed.. Berlin a.o.: Springer; 1999;
  33. Cameron AE, Bashshur RL, Halbritter K, Johnson EM, Cameron JW. Simulation methodology for estimating financial effects of telemedicine in West Virginia. Telemed. J. 1998;4(2):125–144
  34. Moehr JR, Schaafsma J, Anglin C, Pantazi SV, Grimm NA, Anglin S. Success factors for telehealth—a case study. Int. J. Med. Inform. 2006;75(10–11):755–763
  35. I. Koster, L. von Ferber, P. Ihle, I. Schubert, H. Hauner, The cost burden of diabetes mellitus: the evidence from Germany—the CoDiM study, Diabetologia 49 (7) (2006) 1498–1504 (Epub May 11 2006).
  36. Biermann E. Sparen Prävention und Therapie Folgekosten beim Type-2-Diabetes ein? Computermodelle mit virtuellen Patienten folgen großen Interventionsstudien nach (Does prevention and therapy save follow-up costs in type 2 diabetes? Computer models with virtual patients are succeeding large intervention trials, in German). Diabetologie und Stoffwechsel. 2006;1:245–251
  37. Palmer AJ, Roze S, Valentine WJ, Minshall ME, Foos V, Lurati FM, et al. The CORE diabetes model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making. Curr. Med. Res. Opin. August 2004;20(Suppl. 1):S5–S26
  38. Roze S, Valentine WJ, Zakrzewska KE, Palmer AJ. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of type 1 diabetes in the UK. Diab. Med. 2005;22(September (9)):1239–1245

PII: S1386-5056(07)00117-7

doi: 10.1016/j.ijmedinf.2007.06.002

International Journal of Medical Informatics
Volume 76 , Pages S447-S455 , December 2007

Article Tools

* Image Usage & Resolution